期刊： INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2022; 37 (2)
Purpose Over 50% of patients suffering from Crohn's disease (CD) require surgery in their lifetime. Predictors/risk factors of post-operative morbidit......
期刊： INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2022; 37 (5)
Background It remains unclear whether minimally invasive colorectal cancer (CRC) surgery under the suitable management of perioperative antithrombotic......
期刊： INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2022; 37 (5)
Purpose We aimed to compare the diagnostic accuracy of perioperative Delta cfDNA to Delta CEA (over the first 2 years post-operatively) for identifyin......
期刊： INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2022; 37 (6)
Purpose This research aimed to explore prognostic factors for early-onset colorectal cancer (EO-CRC) patients with liver metastasis (LM) and develop n......
期刊： INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2022; 37 (10)
Aim The purpose of this study was to explore the clinical factors associated with achieving good response after neoadjuvant chemoradiotherapy (nCRT) i......
期刊： INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2022; 37 (12)
Purpose Develop a prediction model to determine the probability of no lymph node metastasis (pN0) in patients with colorectal cancer. Methods We used ......
期刊： INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2022; 37 (1)
Background The risk of neoplasia of the pouch or residual rectum in patients with ulcerative colitis (UC) who undergo total proctocolectomy (TPC) with......
期刊： INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2022; 37 (1)
Purpose There has been a noted reluctance to offer laparoscopic surgery to Crohn's Disease patients due to the potential risks, and high rate, of conv......
期刊： INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2022; 37 (1)
Background and objective Immune checkpoint inhibitor (ICI) therapies have shown promising prospects in colorectal cancer (CRC) immunotherapy; many cli......
期刊： INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2022; 37 (2)
Purpose The efficacy of fluorouracil + oxaliplatin + irinotecan with bevacizumab (FOLFOXIRI + BV) has been verified for metastatic colorectal cancer (......
期刊： INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2022; 37 (3)
Purpose Although Hartmann's procedure is commonly performed, subsequent reversal is less frequent. The most common reasons for reversal surgery are ad......
期刊： INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2022; 37 (5)
Purpose We evaluated the influence of preoperative treatments with biologics on surgical morbidity in patients with Crohn's disease (CD). Methods We r......
期刊： INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2022; 37 (5)
Purpose Anastomotic leakage (AL) continues to be a challenge after restorative rectal resection (RRR). Various treatment options of AL are available; ......
期刊： INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2022; 37 (8)
Purpose Withdrawal of thiopurines after remission is associated with an increased risk of relapse in patients with inflammatory bowel disease (IBD). H......
